While the entire MIND cohort was enriched with males (64% of whole cohort), LRRK2 G2019S carriers with PD differed in the proportion of males to females compared to non-carriers (exact p = 0.024, corrected p = 0.048); 49%, 95% CI 26–93, of LRRK2 G2019S carriers were males. This evidence concerns the gene LRRK2 and Parkinson disease.